Vivos Therapeutics (VVOS) Earnings Date, Estimates & Call Transcripts $2.38 +0.02 (+0.85%) (As of 07/2/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 21EstimatedActual EPS (May. 14) -$1.63 Missed By -$1.63 Get Vivos Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for VVOS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVVOS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VVOS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsThe Only Retirement Stock You'll Ever Need? Discover NowThere is a little region of America called Loudoun County. The value of each square mile has shot up close to $10 billion... It's also the source of the single greatest investment opportunity of our generation...Get all the urgent details here >>> VVOS Earnings Date and InformationVivos Therapeutics last issued its earnings data on May 14th, 2024. The reported ($1.63) earnings per share (EPS) for the quarter. The business earned $3.42 million during the quarter. Vivos Therapeutics has generated ($10.93) earnings per share over the last year (($10.93) diluted earnings per share). Vivos Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 21st, 2024 based off prior year's report dates.Read More Vivos Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/21/2024(Estimated)------- 5/14/2024Q1 2024-($1.63)($1.63)($1.63)-$3.42 million3/28/2024Q4 2023-($3.05)($3.05)($3.05)-$3.25 million 11/14/2023Q3 2023-($1.75)($1.75)($1.75)-$3.30 million8/16/2023Q2 2023($3.75)($3.75)-($0.12)$3.93 million$3.40 million 6/8/2023Q1 2023($4.25)($5.00)($0.75)($0.33)$3.71 million$3.86 million3/30/2023Q4 2022($5.50)($5.00)+$0.50($0.20)$4.01 million$3.95 million Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/20/2022Q3 2022($6.25)($6.50)($0.25)($0.26)-$4.25 million 5/16/2022Q1 2022($7.25)($6.50)+$0.75($0.26)$4.50 million$3.46 million3/31/2022Q4 2021-($8.50)($8.50)($0.34)$5.11 million$4.39 million11/15/2021Q3 2021($4.00)($6.50)($2.50)($0.26)$4.50 million$4.55 million 8/12/2021Q2 2021($4.50)($4.75)($0.25)($0.19)$3.70 million$4.50 million 5/17/2021Q1 2021($4.25)($4.75)($0.50)($0.19)$3.00 million$3.45 million 3/25/2021Q4 2020($5.25)($12.00)($6.75)($0.48)$2.92 million$3.30 million Vivos Therapeutics Earnings - Frequently Asked Questions When is Vivos Therapeutics's earnings date? Vivos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 21st, 2024 based off last year's report dates. Learn more on VVOS's earnings history. How much revenue does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded annual revenue of $13.36 million. How much profit does Vivos Therapeutics generate each year? Vivos Therapeutics (NASDAQ:VVOS) has a recorded net income of -$13.58 million. VVOS has generated -$10.93 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: CTCX Earnings Date FEMY Earnings Date XAIR Earnings Date NEPH Earnings Date NMTC Earnings Date ICU Earnings Date PYPD Earnings Date AMIX Earnings Date LYRA Earnings Date MBOT Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: BlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings DropApple Stock All-Time Highs: Can AI Outweigh Earnings Jitters? This page (NASDAQ:VVOS) was last updated on 7/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredRe: We’re giving you all this for less than a pair of socksThe Only Trading Tool You'll Need This Year Forget juggling multiple subscriptions and confusing indicator...StockEarnings | Sponsored25th AmendmentIt's not surprising that talk of invoking the 25th Amendment (to remove Biden from office) has surfaced.Stansberry Research | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.